Follow The Filings

Braveheart Bio position history

The shares of Braveheart Bio that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, COM SHS

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q3: 277,778 shares, $5.6M, 0.02% of portfolio, New
Holdings date Value % of holdings Shares Filing date All 13F holders